Ad
related to: tilray stock price prediction 2025 and 2030 release year of date schedulesuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Tilray Brands (NASDAQ: TLRY) is no exception as it looks to be on track for another tough year, with its stock price down more than 40% thus far in 2024, entering trading on Monday.
In short, Tilray's fundamentals might not change significantly by 2030, even if the cannabis sector benefits from more legislative wins. That's why the stock is still not worth investing in today.
Adjusted net loss was $2.2 million, compared to an adjusted net loss of $2.7 million in the prior-year quarter, a 17% improvement year over year, with adjusted net loss per share coming in at zero ...
For the period ending Aug. 31, its sales grew by 13% year over year to $200 million. But of that total, less than one-third (31%) of sales actually came from its cannabis operations.
Industry analysts forecast the market could reach $444 billion by 2030, representing a compound annual growth rate (CAGR) of 34.03% from 2023. ... Tilray has seen its stock price plummet a ...
Heading into the news, Wall Street analysts anticipated Tilray would report sales of $216.3 million for its fiscal second quarter of 2025, ended Nov. 30, but Tilray actually collected just $211 ...
It's not a secret: The cannabis industry has been a major disappointment since Canada legalized recreational use in 2018. Tilray's CEO, Irwin Simon, recently made a bold prediction along those lines.
Despite a broad rally in cannabis, this top Canadian LP has failed to join the party.
Ad
related to: tilray stock price prediction 2025 and 2030 release year of date schedulesuperstockscreener.com has been visited by 10K+ users in the past month